S6G5T3

· Sol-Gel Technologies, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S6G5T3, covering 2021-12-01 to 2021-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of S6G5T3 in the Treatment of Acne Vulgaris [Phase 3]